Corvus Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $12.3M | $109.5M | $63.5M |
| FY2022 | $12.1M | $68.2M | $13.2M |
| FY2023 | $6.9M | $45.6M | $12.6M |
| FY2024 | $36.3M | $68.9M | $8.7M |
| FY2025 | $9.9M | $71.1M | $4.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $12.3M | $109.5M | $63.5M |
| FY2022 | $12.1M | $68.2M | $13.2M |
| FY2023 | $6.9M | $45.6M | $12.6M |
| FY2024 | $36.3M | $68.9M | $8.7M |
| FY2025 | $9.9M | $71.1M | $4.6M |